AF post up at Trials and Fibrillations–European Society of Cardiology updates AF treatment guidelines

August 26, 2012

in AF ablation, Atrial fibrillation

Hey all,

I’m working hard here in Munich.

There was news made today in the AF world.

The European Society of Cardiology has updated its 2010 AF treatment guidelines with a focused update.

Here’s my attempt at a summary of six major focus points over at Trials and Fibrillations on theHeart.org.

JMM

Related posts:

  1. New post up on Trials and Fibrillations over at theHeart.org: The changing role of AF medicines.
  2. New post up on Trials and Fibrillations…Apixaban (Eliquis) was supposed to beat Pradaxa and Xarelto?
  3. Has AF ablation reached first-line status? My Trials & Fibrillations post…
  4. New post up on Trials and Fibrillation blog: Dabigatran, Rivaroxaban and Apixaban

Comments on this entry are closed.

Previous post:

Next post: